March 26 (Reuters) - RXi Pharmaceuticals Corp:
* RXI PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
* RXI PHARMACEUTICALS CORP - QTRLY LOSS PER SHARE $0.84 Source text for Eikon: Further company coverage: